arrow
M

Maria Isabel Achatz

communaute universite grenoble alpes
H指数:36
被引数:6,177

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

一种基于贝叶斯定量分析的基因特异性变异分类方法:更新的专家小组建议改进了TP53生殖细胞变异在Li-Fraumeni综合征中的分类

2025-10-240
OAAI
Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations

基于临床-公共卫生效用的主流肿瘤学中乳腺癌胚系多基因-panel检测:ESMO精准肿瘤学工作组建议

2025-06-150
PREAI
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome (vol 211, 114307, 2024)

HER2状态和乳腺癌患者及Li-Fraumeni综合征患者对新辅助抗HER2治疗的反应(卷211,114307,2024)

2025-05-010
PRE
Personalized screening strategies for TP53 R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriers
2025-02-010
OAAI
Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
2024-09-050
PRE
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
2023-07-1311
OAAI
Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
2022-07-0113
OAAI
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
2021-12-019
OAAI